FI4452260T3 - Aukkoliitoksen modulaattoreita ja niiden käyttö ikään liittyvän silmänpohjan rappeuman hoidossa - Google Patents
Aukkoliitoksen modulaattoreita ja niiden käyttö ikään liittyvän silmänpohjan rappeuman hoidossaInfo
- Publication number
- FI4452260T3 FI4452260T3 FIEP22843707.5T FI22843707T FI4452260T3 FI 4452260 T3 FI4452260 T3 FI 4452260T3 FI 22843707 T FI22843707 T FI 22843707T FI 4452260 T3 FI4452260 T3 FI 4452260T3
- Authority
- FI
- Finland
- Prior art keywords
- compound
- prevents
- use according
- hydrate
- amd
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163292783P | 2021-12-22 | 2021-12-22 | |
| PCT/EP2022/087342 WO2023118366A1 (en) | 2021-12-22 | 2022-12-21 | Gap junction modulators and their use for the treatment of age-related macular degeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI4452260T3 true FI4452260T3 (fi) | 2026-03-30 |
Family
ID=84981302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP22843707.5T FI4452260T3 (fi) | 2021-12-22 | 2022-12-21 | Aukkoliitoksen modulaattoreita ja niiden käyttö ikään liittyvän silmänpohjan rappeuman hoidossa |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250018002A1 (https=) |
| EP (1) | EP4452260B1 (https=) |
| JP (1) | JP2025500123A (https=) |
| CN (1) | CN118450892A (https=) |
| CA (1) | CA3240515A1 (https=) |
| DK (1) | DK4452260T3 (https=) |
| FI (1) | FI4452260T3 (https=) |
| IL (1) | IL313729A (https=) |
| WO (1) | WO2023118366A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202310195D0 (en) * | 2023-07-03 | 2023-08-16 | Hastings Nataly | Method for mitigating symptoms of neurological condition and a system therefor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6259296A (ja) | 1985-09-10 | 1987-03-14 | Green Cross Corp:The | ペプタイド誘導体 |
| IL157447A0 (en) | 2001-02-22 | 2004-03-28 | Zealand Pharma As Zealand Phar | New medical uses of intercellular communication facilitating compounds |
| UA96283C2 (uk) | 2005-12-23 | 2011-10-25 | Зіланд Фарма А/С | Модифіковані міметики лізину |
| PL2468724T3 (pl) | 2006-12-21 | 2016-05-31 | Zealand Pharma As | Synteza związków pirolidynowych |
| JP6989864B2 (ja) * | 2017-05-05 | 2022-02-03 | ジーランド ファーマ，アー／エス | ギャップ結合細胞間コミュニケーションモジュレータ及び糖尿病性眼疾患の治療のためのそれらの使用 |
-
2022
- 2022-12-21 CN CN202280084727.5A patent/CN118450892A/zh active Pending
- 2022-12-21 IL IL313729A patent/IL313729A/en unknown
- 2022-12-21 US US18/708,367 patent/US20250018002A1/en active Pending
- 2022-12-21 CA CA3240515A patent/CA3240515A1/en active Pending
- 2022-12-21 WO PCT/EP2022/087342 patent/WO2023118366A1/en not_active Ceased
- 2022-12-21 DK DK22843707.5T patent/DK4452260T3/da active
- 2022-12-21 FI FIEP22843707.5T patent/FI4452260T3/fi active
- 2022-12-21 EP EP22843707.5A patent/EP4452260B1/en active Active
- 2022-12-21 JP JP2024529338A patent/JP2025500123A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023118366A1 (en) | 2023-06-29 |
| CA3240515A1 (en) | 2023-06-29 |
| US20250018002A1 (en) | 2025-01-16 |
| EP4452260B1 (en) | 2026-01-28 |
| EP4452260A1 (en) | 2024-10-30 |
| JP2025500123A (ja) | 2025-01-09 |
| IL313729A (en) | 2024-08-01 |
| CN118450892A (zh) | 2024-08-06 |
| DK4452260T3 (da) | 2026-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yadav et al. | Glaucoma: Current treatment and impact of advanced drug delivery systems | |
| CN101679328B (zh) | 老年黄斑变性的预防或治疗剂 | |
| CN1126072A (zh) | 减低眼内压的眼用制剂 | |
| US10973758B2 (en) | Methods of eye treatment using therapeutic compositions containing dipyridamole | |
| Chen et al. | Nonsteroidal anti-inflammatory drugs for retinal neurodegenerative diseases | |
| US5527831A (en) | Pharmaceutical composition for topical application to the eye for treating increased intraocular pressure | |
| FI4452260T3 (fi) | Aukkoliitoksen modulaattoreita ja niiden käyttö ikään liittyvän silmänpohjan rappeuman hoidossa | |
| CA2905594A1 (en) | Compositions for use in treating eye disorders using dipyridamole | |
| KR20210062586A (ko) | 안질환 예방 또는 치료용 점안 조성물 | |
| WO2019024433A1 (zh) | 氨基金刚烷胺单硝酸酯类化合物眼用组合物及其制剂和应用 | |
| JP2005525408A (ja) | アンフェナクまたはネパフェナクを用いる血管内皮増殖因子媒介性血管障害の処置方法 | |
| TW202345853A (zh) | 無防腐劑的眼科藥物乳劑及其應用 | |
| Thumann et al. | Tolbutamide eye drops increase aqueous humor outflow and lower intraocular pressure: a proof of concept for glaucoma treatment | |
| JP2022521647A (ja) | 虚血症状、低酸素症状、低酸素誘導因子に関連する症状、または活性酸素種に関連する症状の酸素含有液体を伴う治療 | |
| Rafuse | Ocular Pharmacology | |
| US20250387331A1 (en) | Prostaglandin analogs and methods for sustained glaucoma management | |
| RU2585400C2 (ru) | Лекарственная форма на основе бутиламиногидроксипропоксифеноксиметил метилоксадиазола | |
| WO2013110152A1 (pt) | Composições farmacêuticas contendo ativadores do eixo enzima conversora de angiotensina 2/angiotensina- (1 -7)/receptor mas para tratamento de patologias oculares | |
| JPWO2023118366A5 (https=) | ||
| US20040259844A1 (en) | Method and composition for preventing, reducing and reversing ocular ischemic neuronal damage | |
| Rojanapongpun et al. | Medical Therapy in Angle Closure Glaucoma | |
| ALTAŞ | Angle Closure Glaucoma and Management in Geriatric Population | |
| Janicka et al. | Secondary Neovascular Glaucoma in the Course of Diabetes in a Kidney Transplant Recipient: Case Report and Review of the Literature | |
| US20080318939A1 (en) | Methods for treating ophthalmic disorders | |
| Thygesen | Treatment of Glaucoma with or without Medications Lowering Intraocular Pressure: Options and Relevant General Health Issues |